SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-015932
Filing Date
2019-08-15
Accepted
2019-08-15 06:01:06
Documents
3
Period of Report
2019-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k081419_cormedixinc.htm 8-K 34324
2 SECURITIES EXCHANGE AGREEMENT, DATED AUGUST 14, 2019, BY AND AMONG CORMEDIX INC. f8k081419ex10-1_cormedixinc.htm EX-10.1 273044
3 PRESS RELEASE, DATED AUGUST 14, 2019 f8k081419ex99-1_cormedixinc.htm EX-99.1 9147
  Complete submission text file 0001213900-19-015932.txt   317906
Mailing Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922
Business Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 191028369
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1